What is the recommended treatment for someone exposed to gonorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Gonorrhea Exposure

Treat all individuals exposed to gonorrhea with the same dual therapy regimen used for confirmed infection: ceftriaxone 500 mg IM plus doxycycline 100 mg orally twice daily for 7 days (or azithromycin 1 g orally as a single dose if compliance is uncertain). 1, 2

Rationale for Presumptive Treatment

  • Gonorrhea transmission rates are high enough to warrant immediate treatment without waiting for test results, particularly because many infections are asymptomatic and patients may not return for follow-up 3
  • Co-infection with Chlamydia trachomatis occurs in 10-50% of gonorrhea cases, making dual therapy essential even for presumptive treatment 3, 1
  • The CDC explicitly recommends that all sexual partners from the preceding 60 days should be evaluated and treated for both gonorrhea and chlamydia, regardless of symptoms or test results 1

Recommended Treatment Regimen

Primary regimen:

  • Ceftriaxone 500 mg IM as a single dose 1, 2
  • PLUS doxycycline 100 mg orally twice daily for 7 days 2

Alternative if compliance is a concern:

  • Ceftriaxone 500 mg IM as a single dose 1
  • PLUS azithromycin 1 g orally as a single dose 1

The azithromycin option provides single-dose convenience but is less preferred due to antimicrobial stewardship concerns and increasing azithromycin resistance 2. However, for exposed partners who may not complete a 7-day course, the single-dose regimen is more practical 1.

Special Considerations for Partner Management

  • Expedited partner therapy (EPT) may be considered when partners cannot be linked to timely evaluation, using oral combination therapy: cefixime 400 mg plus azithromycin 1 g orally 1, 4, 5
  • EPT is NOT recommended for men who have sex with men (MSM) due to high risk of undiagnosed coexisting STDs or HIV 1
  • Partners should avoid sexual intercourse until therapy is completed and both individuals are asymptomatic 1

Critical Pitfalls to Avoid

  • Never use quinolones (ciprofloxacin, ofloxacin) for gonorrhea treatment or prophylaxis due to widespread resistance, despite their historical effectiveness 1, 2
  • Never use azithromycin 1 g alone for gonorrhea treatment—it has only 93% efficacy and risks rapid resistance emergence 1
  • Do not use cefixime as first-line therapy—it is only acceptable when ceftriaxone is unavailable, and requires mandatory test-of-cure at 1 week 1, 4

Pregnancy Considerations

  • Pregnant women exposed to gonorrhea should receive the same dual therapy: ceftriaxone 500 mg IM plus azithromycin 1 g orally 1, 6, 7
  • Never use doxycycline, quinolones, or tetracyclines in pregnancy 1

Follow-Up Requirements

  • Patients treated with the recommended ceftriaxone-based regimen do not need routine test-of-cure unless symptoms develop 1, 6
  • Retest all patients at 3 months due to high reinfection risk (most "treatment failures" are actually reinfections) 1, 6, 7
  • If symptoms persist after treatment, obtain culture with antimicrobial susceptibility testing immediately 1

Transmissibility Context

  • Gonorrhea is highly transmissible, with transmission occurring even from asymptomatic individuals 3
  • Many infections in women remain asymptomatic until complications like pelvic inflammatory disease develop, which can lead to tubal scarring, infertility, or ectopic pregnancy 3
  • The high transmissibility and potential for serious sequelae justify aggressive partner treatment strategies 2

References

Guideline

Gonorrhea Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020.

MMWR. Morbidity and mortality weekly report, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.